[1] ZHOU Y,LI Y,ZHOU T,et al.Dietary natural products for prevention and treatment of liver cancer[J].Nutrients,2016,8(3):156.
[2] 戴峰,朱西琪.索拉非尼在中晚期肝细胞肝癌治疗中的临床价值[J].东南大学学报(医学版),2016,35(1):106-108.
[3] INDUMATHY S,DASS C R.Finding chemo:the search for marine-based pharmaceutical drugs active against cancer[J].J Pharm Pharmacol,2013,65(9):1280-1301.
[4] NEWMAN D J,CRAGG G M.Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development[J].Mar Drugs,2014,12(1):255-278.
[5] LI P,DIAB S,YU M,et al.Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells[J].Oncotarget,2016,7(35):56811-56825.
[6] MASCILINI F,AMADIO G,DI STEFANO M G,et al.Clinical utility of trabectedin for the treatment of ovarian cancer:current evidence[J].Onco Targets Ther,2014,7:1273-1284.
[7] CHEN R,WANG F,ZHANG H,et al.Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma:results of a systematic review and meta-analysis of prospective studies[J].Drug Des Devel Ther,2015,9:2277-2283.
[8] MUKHERJEE A,WILLIAMS D W.More alive than dead:non-apoptotic roles for caspases in neuronal development,plasticity and disease[J].Cell Death Differ,2017,24(8):1411-1421.
[9] SAVITSKAYA M A,ONISHCHENKO G E.Mechanisms of Apoptosis[J].Biochemistry,2015,80(11):1393-1405.
[10] GOLDAR S,KHANIANI M S,DERAKHSHAN S M,et al.Molecular mechanisms of apoptosis and roles in cancer development and treatment[J].Asian Pac J Cancer Prev,2015,16(6):2129-2144.
[11] WANG Y,QI X,LI D,et al.Anticancer efficacy and absorption,distribution,metabolism,and toxicity studies of aspergiolide A in early drug development[J].Drug Des Devel Ther,2014,8:1965-1977.
[12] JIANG Y,MIAO Z H,XU L,et al.Drug transporter-independent liver cancer cell killing by a marine steroid methyl spongoate via apoptosis induction[J].J Biol Chem,2011,286(30):26461-26469.
[13] WU N,LUO J,JIANG B,et al.Marine bromophenol bis (2,3-dibromo-4,5-dihydroxy-phenyl)-methane inhibits the proliferation,migration,and invasion of hepatocellular carcinoma cells via modulating beta1-integrin/FAK signaling[J].Mar Drugs,2015,13(2):1010-1025.
[14] VELA L,MARZO I.Bcl-2 family of proteins as drug targets for cancer chemotherapy:the long way of BH3 mimetics from bench to bedside[J].Curr Opin Pharmacol,2015,23:74-81.
[15] HALIM H,CHUNHACHA P,SUWANBORIRUX K,et al.Anticancer and antimetastatic activities of Renieramycin M,a marine tetrahydroisoquinoline alkaloid,in human non-small cell lung cancer cells[J].Anticancer Res,2011,31(1):193-201.
[16] WU Y J,WONG B S,YEA S H,et al.Sinularin induces apoptosis through mitochondria dysfunction and inactivation of the pI3K/Akt/mTOR pathway in gastric carcinoma cells[J].Mar Drugs,2016,14(8),142.
[17] CHUNG T W,LIN S C,SU J H,et al.Sinularin induces DNA damage,G2/M phase arrest,and apoptosis in human hepatocellular carcinoma cells[J].BMC Complement Altern Med,2017,17(1):62.
[18] CHEN Y J,SU J H,TSAO C Y,et al.Sinulariolide induced hepatocellular carcinoma apoptosis through activation of mitochondrial-related apoptotic and PERK/eIF2alpha/ATF4/CHOP pathway[J].Molecules,2013,18(9):10146-10161.
[19] LIN J J,SU J H,TSAI C C,et al.11-epi-Sinulariolide acetate reduces cell migration and invasion of human hepatocellular carcinoma by reducing the activation of ERK1/2,p38MAPK and FAK/PI3K/AKT/mTOR signaling pathways[J].Mar Drugs,2014,12(9):4783-4798.
[20] HIENTZ K,MOHR A,BHAKTA-GUHA D,et al.The role of p53 in cancer drug resistance and targeted chemotherapy[J].Oncotarget,2017,8(5):8921-8946.
[21] ABDEL-LATEFF A,AL-ABD A M,ALAHDAL A M,et al.Antiproliferative effects of triterpenoidal derivatives,obtained from the marine sponge Siphonochalina sp.,on human hepatic and colorectal cancer cells[J].Z Naturforsch C,2016,71(1-2):29-35.
[22] MEHRPOUR M,ESCLATINE A,BEAU I,et al.Overview of macroautophagy regulation in mammalian cells[J].Cell Res,2010,20(7):748-762.
[23] ZHAO Y,CHEN H,SHANG Z,et al.SD118-xanthocillin X (1),a novel marine agent extracted from Penicillium commune,induces autophagy through the inhibition of the MEK/ERK pathway[J].Mar Drugs,2012,10(6):1345-1359. |